Register and share your invite link to earn from video plays and referrals.

Search results for USIPO
USIPO community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including USIPO
Hawkeye 360, a provider of satellite-based signals intelligence for US government agencies, is raising $416 million in a USIPO priced at the top of a marketed range, sources say
Show more
🚀 SK hynix (SKHY) IPO is Now Available on BiFinance! One of the world's leading semiconductor companies and the global leader in AI High Bandwidth Memory (HBM) is now available through BiFinance IPO. 🔥 IPO Highlights 💰 The offering is expected to raise approximately US$26.5 billion, making it the largest U.S. IPO ever by a foreign company, surpassing Alibaba's previous record of US$25 billion. 📈 Investor demand has been exceptionally strong, with the IPO already oversubscribed by more than 7x and total subscription interest approaching US$200 billion. 📌 Code: SKHY 💵 Price per Share: US$158.14 🕓 Subscription Time: 2026/07/10 16:00 (UTC+8) Don't miss the opportunity to invest in one of the world's most important AI memory semiconductor leaders. Join now via: #BiFinance# #IPO# #SKHynix# #SKHY# #AI# #HBM# #Semiconductor# #Memory# #Investing# #USIPO#
Show more
Unipol chair pledges to keep MPS headquarters in Siena
US IPO issuance has surged to record highs in 2026, raising concerns over late-cycle market dynamics and equity supply absorption. Jay Ritter of The IPO Initiative at the University of Florida’s Warrington College of Business (@UF) and Owen Lamont of Acadian Asset Management discuss their views about recent investor apprehensions over the record issuance on Exchanges: Top of Mind:
Show more
CONSENSYS POSTPONES US IPO TO FALL 2026
Swiss dental startup vVardis downsizes US IPO by more than 12%
Swiss dental startup vVardis downsizes US IPO by more than 12%
Crypto firm Redotpay is considering a confidential US IPO filing by year-end after months of regulatory wrangling, people familiar with the matter said
Swiss drug developer Windward Bio files for US IPO